10-Q: Upexi Inc. Reports Mixed Results in Q2 2024, Revenue Declines Amidst Strategic Shifts
Quarterly Report
Upexi Inc. experienced a decrease in revenue and a net loss in the second quarter of 2024, as the company navigates strategic shifts and consolidates operations.
Summary
- Upexi Inc. reported a revenue of $21.8 million for the three months ended December 31, 2023, a decrease of 18% compared to $26.7 million in the same period last year.
- The company's cost of revenue also decreased by 19% to $13.6 million, down from $16.7 million in the prior year.
- Gross profit decreased to $8.3 million from $10.1 million year-over-year.
- Operating expenses totaled $10.1 million, compared to $11.8 million in the same period last year.
- The company reported a net loss of $2.4 million for the quarter, compared to a net income of $2.7 million in the same period last year.
- For the six months ended December 31, 2023, revenue increased by 30% to $49.2 million, compared to $38.0 million in the same period last year.
- The company's net loss for the six months was $3.8 million, compared to a net income of $72,164 in the same period last year.
- The company's working capital was negative $1.7 million as of December 31, 2023, compared to a positive $5.8 million as of June 30, 2023.
Sentiment
Score: 4
Explanation: The document presents a mixed picture with a significant revenue decline and a net loss, but also some positive cost-cutting measures. The ineffective internal controls and negative working capital are concerning, leading to a below-average sentiment score.
Positives
- The company's cost of revenue decreased by 19% in the three months ended December 31, 2023, compared to the same period in 2022.
- Sales and marketing expenses decreased by 18% in the three months ended December 31, 2023, compared to the same period in 2022.
- Distribution costs decreased by 9% in the three months ended December 31, 2023, compared to the same period in 2022.
- General and administrative expenses decreased by 9% in the three months ended December 31, 2023, compared to the same period in 2022.
- Other operating expenses decreased by 24% in the three months ended December 31, 2023, compared to the same period in 2022.
- For the six months ended December 31, 2023, revenue increased by 30% year-over-year.
- The company has consolidated its Delray Beach facility with the Tampa Bay facility.
Negatives
- The company's revenue decreased by 18% in the three months ended December 31, 2023, compared to the same period in 2022.
- The company experienced a net loss of $2.4 million for the quarter, a significant shift from the $2.7 million net income in the same period last year.
- The company's gross profit decreased by approximately $1.8 million year-over-year.
- The company's net loss for the six months was $3.8 million, compared to a net income of $72,164 in the same period last year.
- The company's working capital was negative $1.7 million as of December 31, 2023.
- The company was not in compliance with the debt service ratio on its mortgage loan as of December 31, 2023.
Risks
- The company faces uncertainties related to the regulation of cannabinoids.
- The company's internal controls over financial reporting were deemed ineffective due to material weaknesses.
- The company is not in compliance with the debt service ratio on its mortgage loan.
- The company has a negative working capital of $1.7 million.
Future Outlook
The company anticipates that advertising expenses will be reduced over time as a percentage of sales, which will increase overall profitability. Management believes that its strategy to focus on direct-to-consumer sales channels will yield significant returns in the next 12 months. The company estimates that it will have sufficient working capital to fund operations over the next twelve months and meet all debt obligations.
Management Comments
- Management will continue to focus on the development and growth of the high gross margin Branded Product sales.
- Management will seek to improve the gross profit and the overall gross margin in the next 12 months.
- Management will continue to strategically increase the sales and marketing budget for our direct to consumer sales channels.
- Management will continue its efforts to consolidate and streamline our distribution network and decrease the costs as a percentage of revenue.
- Management has managed the general and administrative costs and will continue to implement strategies to decrease the percentage of general and administrative costs when compared to total sales.
Industry Context
Upexi operates in the e-commerce sector, focusing on direct-to-consumer and Amazon brands. The company's performance is influenced by trends in online retail, consumer spending, and the competitive landscape of the health, wellness, pet, and beauty markets. The company's strategic shift towards branded products and away from manufacturing aligns with a broader trend of companies focusing on core competencies and higher-margin activities.
Comparison to Industry Standards
- Upexi's revenue decline of 18% in the three months ended December 31, 2023, contrasts with the overall growth seen in the e-commerce sector during the same period, where many companies experienced growth due to holiday sales.
- The company's negative working capital of $1.7 million is a concern, as many e-commerce companies maintain a positive working capital to ensure smooth operations and growth.
- The company's net loss of $2.4 million for the quarter is a significant deviation from the net income of $2.7 million in the same period last year, indicating potential challenges in profitability compared to industry benchmarks.
- The company's gross profit margin decreased year-over-year, which is a concern as many e-commerce companies focus on improving gross margins to drive profitability.
- Compared to companies like Amazon, which have robust distribution networks, Upexi is still working to consolidate and streamline its distribution network to reduce costs.
- The company's reliance on acquisitions for growth is a common strategy in the e-commerce sector, but the company needs to ensure that these acquisitions are integrated effectively and contribute to profitability.
Related Party Transactions
- The company entered into a promissory note with Allan Marshall, the company's CEO, for $1,500,000 with an interest rate of 8.5% per annum with an additional PIK of 3.5% per annum. The note was amended on November 15, 2023, to provide for interest-only payments for 18 months at 12% per annum and then amortization over 12 months starting in June 2025.
Stakeholder Impact
- Shareholders may be concerned about the company's revenue decline, net loss, and negative working capital.
- Employees may be affected by the company's cost-cutting measures and consolidation efforts.
- Customers may experience changes in product availability or service as the company consolidates operations.
- Suppliers may be impacted by the company's efforts to streamline its distribution network.
- Creditors may be concerned about the company's negative working capital and non-compliance with debt service ratios.
Next Steps
- The company plans to implement the appointment of additional qualified personnel to address inadequate segregation of duties and implement modifications to our financial controls by the end of the 2024 fiscal year.
- The company will continue to monitor and evaluate the effectiveness of its internal controls and procedures and its internal controls over financial reporting on an ongoing basis.
- The company will continue to focus on sales growth while continuing to improve net income through the consolidation of operations.
Key Dates
| Date | Description |
|---|---|
| 2021-08-01 | Date of original promissory note related to the purchase of VitaMedica. |
| 2022-04-01 | Date the company acquired 55% of Cygnet Online, LLC. |
| 2022-04-15 | Date of original non-negotiable convertible promissory note (Cygnet Note). |
| 2022-06-28 | Date the company entered into a senior secured convertible notes agreement. |
| 2022-07-31 | Date the company received and deposited the principal amount of the Marshall Loan. |
| 2022-08-12 | Date the company entered into an asset purchase agreement with GA Solutions, LLC (LuckyTail). |
| 2022-10-19 | Date the company entered into a loan agreement with Professional Bank. |
| 2022-10-21 | Date the company acquired E-Core Technology, Inc. |
| 2022-10-26 | Date the company entered into a membership interest purchase agreement to sell Infusionz LLC. |
| 2023-02-22 | Date the company executed a promissory note with an investor. |
| 2023-08-31 | Date the company sold Interactive Offers, LLC. |
| 2023-09-01 | Date the company purchased the remaining 45% of Cygnet Online, LLC. |
| 2023-11-15 | Date the company executed an amendment to the promissory note with Mr. Marshall. |
| 2024-01-18 | Date the company issued 501,605 shares of common stock as repayment of long-term debt. |
| 2024-02-13 | Latest practicable date for share count, with 20,889,384 shares outstanding. |
Keywords
Upexi, financial results, quarterly report, revenue, net loss, acquisitions, e-commerce, Amazon, branded products, recommerce, operating expenses, debt, internal controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.